Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Polarityte Inc (PTE)

Polarityte Inc (PTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company PR Newswire - Tue Dec 27, 2022

/PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials (the "Company"), today...

PTE : 0.2410 (-0.82%)
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update PR Newswire - Thu Nov 10, 2022

/PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business...

PTE : 0.2410 (-0.82%)
PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company PR Newswire - Wed Nov 9, 2022

/PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today confirmed that on...

PTE : 0.2410 (-0.82%)
PolarityTE, Inc. (PTE) Upgraded to Strong Buy: Here's What You Should Know Zacks - Thu Oct 13, 2022

PolarityTE, Inc. (PTE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PTE : 0.2410 (-0.82%)
PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update PR Newswire - Thu Aug 11, 2022

/PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business...

PTE : 0.2410 (-0.82%)
PolarityTE, Inc. (PTE) Reports Q1 Loss, Misses Revenue Estimates Zacks - Mon May 16, 2022

PolarityTE, Inc. (PTE) delivered earnings and revenue surprises of -25% and 12.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

PTE : 0.2410 (-0.82%)
TARO : 42.48 (+0.66%)
PLx Pharma, Inc. (PLXP) Reports Q1 Loss, Lags Revenue Estimates Zacks - Fri May 13, 2022

PLx Pharma, Inc. (PLXP) delivered earnings and revenue surprises of 4.35% and 11.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

PLXP : 0.0207 (unch)
PTE : 0.2410 (-0.82%)
Altimmune, Inc. (ALT) Reports Q1 Loss, Misses Revenue Estimates Zacks - Thu May 12, 2022

Altimmune, Inc. (ALT) delivered earnings and revenue surprises of 22.81% and 98.45%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ALT : 7.20 (+1.69%)
PTE : 0.2410 (-0.82%)
PTE Stock Is Rocketing Nearly 100% Today. It’s About Time. InvestorPlace - Tue Apr 12, 2022

PTE stock surges as optimism rises among penny stock investors

PTE : 0.2410 (-0.82%)
Author
Biotech Stocks News: What’s Going on With LIXT, PTE, QLGN and ATNM Stocks Today InvestorPlace - Tue Apr 12, 2022

Microcap biotech stocks are skyrocketing today. Here are the names investors need to know.

SBFM : 0.8074 (-13.18%)
PTE : 0.2410 (-0.82%)
QLGN : 0.2970 (-3.85%)
LIXT : 3.22 (-1.83%)
ATNM : 6.56 (-7.08%)

Barchart Exclusives

This Dividend King Is Now One of BofA's Investment Best Ideas Barchart - Thu Apr 25, 6:30PM CDT
Discover why S&P Global, a seasoned Dividend King, has not only secured a spot on Bank of America's prestigious US 1 List, but also why analysts are bullish about its investment potential in the current economic climate. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot